204 related articles for article (PubMed ID: 35276424)
1. Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
Fantacuzzi M; Amoroso R; Carradori S; De Filippis B
Eur J Med Chem; 2022 Apr; 233():114242. PubMed ID: 35276424
[TBL] [Abstract][Full Text] [Related]
2. Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
Huang J; Huang N; Xu S; Luo Y; Li Y; Jin H; Yu C; Shi J; Jin F
J Nutr Biochem; 2021 Feb; 88():108552. PubMed ID: 33220405
[TBL] [Abstract][Full Text] [Related]
3. Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries.
Foti Cuzzola V; Ciurleo R; Giacoppo S; Marino S; Bramanti P
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):849-62. PubMed ID: 21999735
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
5. More Than Resveratrol: New Insights into Stilbene-Based Compounds.
Pecyna P; Wargula J; Murias M; Kucinska M
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32726968
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration.
Uddin MS; Al Mamun A; Kabir MT; Ahmad J; Jeandet P; Sarwar MS; Ashraf GM; Aleya L
Eur J Pharmacol; 2020 Nov; 886():173412. PubMed ID: 32771668
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol - A comprehensive review of recent advances in anticancer drug design and development.
Ahmadi R; Ebrahimzadeh MA
Eur J Med Chem; 2020 Aug; 200():112356. PubMed ID: 32485531
[TBL] [Abstract][Full Text] [Related]
8. Aza- and Azo-Stilbenes: Bio-Isosteric Analogs of Resveratrol.
Lizard G; Latruffe N; Vervandier-Fasseur D
Molecules; 2020 Jan; 25(3):. PubMed ID: 32019195
[TBL] [Abstract][Full Text] [Related]
9. Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents.
Viegas FPD; Gontijo VS; de Freitas Silva M; Ortiz CJC; Dos Reis Rosa Franco G; Ernesto JT; Damasio CM; Silva IMF; Campos TG; Viegas C
Curr Neuropharmacol; 2022; 20(7):1297-1328. PubMed ID: 34825873
[TBL] [Abstract][Full Text] [Related]
10. The Use of Stilbene Scaffold in Medicinal Chemistry and Multi- Target Drug Design.
Giacomini E; Rupiani S; Guidotti L; Recanatini M; Roberti M
Curr Med Chem; 2016; 23(23):2439-89. PubMed ID: 27183980
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view.
de Oliveira MR; Nabavi SF; Manayi A; Daglia M; Hajheydari Z; Nabavi SM
Biochim Biophys Acta; 2016 Apr; 1860(4):727-45. PubMed ID: 26802309
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-Mediated Regulation of Mitochondria Biogenesis-associated Pathways in Neurodegenerative Diseases: Molecular Insights and Potential Therapeutic Applications.
Shaito A; Al-Mansoob M; Ahmad SMS; Haider MZ; Eid AH; Posadino AM; Pintus G; Giordo R
Curr Neuropharmacol; 2023; 21(5):1184-1201. PubMed ID: 36237161
[TBL] [Abstract][Full Text] [Related]
13. Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol.
Micale N; Molonia MS; Citarella A; Cimino F; Saija A; Cristani M; Speciale A
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361819
[TBL] [Abstract][Full Text] [Related]
14. On the Neuroprotective Effects of Naringenin: Pharmacological Targets, Signaling Pathways, Molecular Mechanisms, and Clinical Perspective.
Nouri Z; Fakhri S; El-Senduny FF; Sanadgol N; Abd-ElGhani GE; Farzaei MH; Chen JT
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31684142
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological activities and structure-modification of resveratrol analogues.
Xiao Y; Chen H; Song C; Zeng X; Zheng Q; Zhang Y; Lei X; Zheng X
Pharmazie; 2015 Dec; 70(12):765-71. PubMed ID: 26817272
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence.
Socała K; Żmudzka E; Lustyk K; Zagaja M; Brighenti V; Costa AM; Andres-Mach M; Pytka K; Martinelli I; Mandrioli J; Pellati F; Biagini G; Wlaź P
Phytother Res; 2024 Mar; 38(3):1400-1461. PubMed ID: 38232725
[TBL] [Abstract][Full Text] [Related]
17. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity.
Doré S
Neurosignals; 2005; 14(1-2):61-70. PubMed ID: 15956815
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review.
Jang JY; Im E; Kim ND
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430164
[TBL] [Abstract][Full Text] [Related]
19. Hybrid
Piekuś-Słomka N; Mikstacka R; Ronowicz J; Sobiak S
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875859
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol: new avenues for a natural compound in neuroprotection.
Pallàs M; Porquet D; Vicente A; Sanfeliu C
Curr Pharm Des; 2013; 19(38):6726-31. PubMed ID: 23530512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
